These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 37548030)
1. Antibody-mediated rejection in xenotransplantation: Can it be prevented or reversed? Habibabady Z; McGrath G; Kinoshita K; Maenaka A; Ikechukwu I; Elias GF; Zaletel T; Rosales I; Hara H; Pierson RN; Cooper DKC Xenotransplantation; 2023; 30(4):e12816. PubMed ID: 37548030 [TBL] [Abstract][Full Text] [Related]
2. Xenotransplantation--state of the art--update 1999. Bühler L; Friedman T; Iacomini J; Cooper DK Front Biosci; 1999 Apr; 4():D416-32. PubMed ID: 10209058 [TBL] [Abstract][Full Text] [Related]
3. Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantation. Yerly P; Rotman S; Regamey J; Aubert V; Aur S; Kirsch M; Hullin R; Pascual M Xenotransplantation; 2022 Jan; 29(1):e12726. PubMed ID: 35001433 [TBL] [Abstract][Full Text] [Related]
4. Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantation. Schwotzer N; Paganetti G; Barchi M; Perrottet N; Aubert V; Sadallah S; Rotman S; Venetz JP; Matter M; Golshayan D; Pascual M Xenotransplantation; 2020 Jul; 27(4):e12630. PubMed ID: 32698246 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience. Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J Clin Transpl; 2014; ():223-30. PubMed ID: 26281149 [TBL] [Abstract][Full Text] [Related]
6. The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-to-rat cardiac xenografts. Pruitt SK; Baldwin WM; Barth RN; Sanfilippo F Transplantation; 1993 Dec; 56(6):1318-24. PubMed ID: 8278996 [TBL] [Abstract][Full Text] [Related]
7. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide. Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273 [TBL] [Abstract][Full Text] [Related]
8. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts. Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis. Kobayashi T; Yokoyama I; Morozumi K; Nagasaka T; Hayashi S; Uchida K; Takagi H; Nakao A Xenotransplantation; 2000 May; 7(2):101-8. PubMed ID: 10961294 [TBL] [Abstract][Full Text] [Related]
10. A perspective on the potential detrimental role of inflammation in pig orthotopic heart xenotransplantation. Thompson CP; Jagdale A; Walcott G; Iwase H; Foote JB; Cron RQ; Hara H; Cleveland DC; Cooper DKC Xenotransplantation; 2021 Jul; 28(4):e12687. PubMed ID: 33786912 [TBL] [Abstract][Full Text] [Related]
11. Recent progress in the pig-to-nonhuman primate kidney transplantation model: Report of a symposium. Cooper DKC Xenotransplantation; 2022 Jan; 29(1):e12728. PubMed ID: 35001421 [TBL] [Abstract][Full Text] [Related]
12. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation. Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509 [TBL] [Abstract][Full Text] [Related]
13. Anti-C5 Antibody Tesidolumab Reduces Early Antibody-mediated Rejection and Prolongs Survival in Renal Xenotransplantation. Adams AB; Lovasik BP; Faber DA; Burlak C; Breeden C; Estrada JL; Reyes LM; Vianna RM; Tector MF; Tector AJ Ann Surg; 2021 Sep; 274(3):473-480. PubMed ID: 34238812 [TBL] [Abstract][Full Text] [Related]
14. Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection. Jordan SC; Vo AA; Toyoda M; Tyan D; Nast CC Pediatr Transplant; 2005 Apr; 9(2):155-61. PubMed ID: 15787786 [TBL] [Abstract][Full Text] [Related]
15. Serum Antibody Binding and Cytotoxicity to Pig Cells in Chinese Subjects: Relevance to Clinical Renal Xenotransplantation. Li T; Feng H; Du J; Xia Q; Cooper DKC; Jiang H; He S; Pan D; Chen G; Wang Y Front Immunol; 2022; 13():844632. PubMed ID: 35418974 [TBL] [Abstract][Full Text] [Related]
18. Current and future prospects for xenotransplantation. French AJ; Greenstein JL; Loveland BE; Mountford PS Reprod Fertil Dev; 1998; 10(7-8):683-96. PubMed ID: 10612477 [TBL] [Abstract][Full Text] [Related]
19. The Long and Winding Road to Clinical Xenotransplantation: A Personal Journey. Cooper DKC Eur Surg Res; 2022; 63(4):165-172. PubMed ID: 35764060 [TBL] [Abstract][Full Text] [Related]
20. Bringing Home The Bacon: Update on The State of Kidney Xenotransplantation. Cooper DKC; Iwase H; Wang L; Yamamoto T; Li Q; Li J; Zhou H; Hara H Blood Purif; 2018; 45(1-3):254-259. PubMed ID: 29478054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]